In the current month, FBRX has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. FBRX average Analyst price target in the last month is 71.667.
Based on analysts' estimates, FBRX EPS is projected to reach -0.935 in FY2026Q3, following reported EPS of -0.981 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.98, while Forte Biosciences IncFBRX's earnings per share (EPS) for the previous quarter was USD -1.24. EPS for the next quarter is expected at USD -0.94.